Episode 50 · Published May 22, 2020
For our 50th recording, Jonathan Simons (President and CEO, Prostate Cancer Foundation) and Esther Krofah (Executive Director, FasterCures) join Mike for a special discussion on how breakthroughs in cancer laboratories are advancing our understanding and possible treatment of COVID-19.
The roundtable features six scientists, from academic medical research institutions and the biopharmaceutical industry, sharing their insights on the TMPRSS2 gene’s role as the doorway through which the SARS-CoV-2 virus enters the lung.
That same genetic doorway also happens to play an important role in several forms of cancer. The promising news is that researchers—including those on this call—have learned how to shut that door in other contexts.